Quantinuum Files Publicly Under "QNT" While D-Wave's Bookings Explode 1,994 Percent: The Quantum Sector Is Splitting Into Two Stories

On May 8, Honeywell announced that its quantum computing subsidiary Quantinuum had publicly filed a Form S-1 with the SEC and intends to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol QNT. J.P. Morgan and Morgan Stanley are joint lead book-runners; Jefferies and Evercore round out the active syndicate. The number of shares and the price range have not yet been set. This is the most consequential quantum public filing since IonQ went public in 2021, and it confirms what the prior April 22 confidential submission had only hinted at — the largest privately held full-stack quantum company is going public in 2026.

Four days later, on May 12, D-Wave Quantum reported Q1 2026 results that read like two different companies stapled together. Revenue fell 81 percent year-over-year to $2.9 million. Bookings rose 1,994 percent to a record $33.4 million. Remaining performance obligations — the closest GAAP proxy for backlog — ended the quarter at $42.4 million, up 563 percent year-over-year and 216 percent quarter-over-quarter. Management said roughly 54 percent of that backlog should convert to revenue within twelve months. The market took one look at the $2.9 million headline and the stock dropped 6 percent.

These two events, four days apart, are the cleanest illustration we have seen of the structural split now defining public quantum: the maturing-into-real-revenue cohort, and the still-pricing-the-option cohort. Both are part of the same secular story. Neither will resemble the other on a Bloomberg screen for the next two years.

What Quantinuum's Filing Tells Us About the Quantum Market

Quantinuum is the trapped-ion full-stack pure-play formed in 2021 when Honeywell Quantum Solutions merged with Cambridge Quantum. Honeywell owns roughly 54 percent of the entity. In September 2025, Quantinuum raised $600 million at a $10 billion pre-money valuation with capital from Nvidia's venture arm, JPMorgan, Amgen, and others. Subsequent media reports, repeated in the LinkedIn coverage of the confidential filing, have put the IPO target valuation north of $20 billion with a possible raise around $1 billion — numbers Honeywell has not formally confirmed.

What changed on May 8 is that Quantinuum is now in the SEC's public S-1 review window. The clock has started on the offering's marketing period. Roadshow timing typically lands 2-4 weeks after a public S-1 filing, with pricing 1-2 weeks after that. A summer 2026 listing is now the base case, not a hypothetical. For pre-IPO secondary markets that have been trading Quantinuum shares on platforms like Forge, Hiive, and EquityZen, the bid-ask spread has compressed sharply post-filing, which is the usual pattern as private-market liquidity converges into the public window.

The strategic question is whether QNT lists as a premium-to-peers name or a discount. The case for premium: Quantinuum reportedly approached $200 million in 2025 revenue per Honeywell disclosures — an order of magnitude above IonQ's run rate and two orders of magnitude above Rigetti's. The case for discount: Honeywell retains majority control post-IPO, which typically merits a 10-15 percent governance discount versus widely held peers.

What D-Wave Tells Us About the Other Story

D-Wave's Q1 disconnect — record bookings, collapsed revenue — is a textbook revenue-recognition timing story rather than a demand story. Last year's Q1 included a $12.6 million one-time annealing system sale recognized as point-in-time revenue. This year's Q1 included the FAU university system, the first Fortune 100 Quantum Computing-as-a-Service deal, and 100-plus paying customers, but most of those contracts are subscription or multi-year service arrangements that recognize ratably. The revenue line shows what was earned in 90 days. The bookings line shows what was sold in 90 days.

The market's punishment of the stock is rational on a near-term EPS basis and almost certainly wrong on a forward-revenue basis. RPO is the leading indicator. A backlog of $42.4 million, 54 percent of which converts within twelve months, implies roughly $22.9 million of recognized revenue from existing contracts alone in the next four quarters — before any new bookings are layered on. Q1 2025 revenue, stripped of the one-time hardware sale, was $2.4 million. The underlying recurring business has roughly tripled.

What this teaches educated investors about the sector: quantum revenue does not behave like SaaS revenue, and it does not behave like hardware revenue. It is a hybrid — lumpy systems sales, ratable QCaaS subscriptions, and milestone-driven professional services — that requires a backlog-aware analytical framework rather than a quarterly print framework. The companies that win the next five years will be the ones that convert backlog to recurring at high gross margins. The companies that do not will look like one-quarter wonders.

The Pre-IPO Pipeline Behind QNT

Quantinuum's listing is the headline, but it is the front-runner of a deeper pipeline. PsiQuantum raised $1 billion at the September 2025 close of its Series E, on top of a separately reported $750 million round earlier in the year. The company is targeting first commercial fault-tolerant systems by 2029 and remains private with substantial U.S. and Australian government backing. Infleqtion — the U.S./U.K. quantum hardware and sensing firm spun out of ColdQuanta — has announced a SPAC merger with Churchill Capital Corp X at a pre-money near $1.8 billion. Horizon Quantum Computing is merging with dMY Squared. Both SPAC transactions are slated to close in 2026.

Said differently: the public quantum cohort, which today consists of four pure-plays (IonQ, D-Wave, Rigetti, Quantum Computing Inc.) plus a constellation of post-quantum-cryptography and software names, is on track to double in 2026. That kind of cohort expansion typically drives a multi-quarter rerating across the sector as new comparables emerge, sell-side coverage expands, and index inclusion debates begin. It also typically introduces a wider valuation dispersion as the market starts to differentiate quality from speculation.

The Educated Takeaway

Quantum computing is no longer one trade. It is at least three: the maturing-revenue trade (Quantinuum, IonQ on backlog growth), the optionality trade (PsiQuantum, fault-tolerant photonic plays, the small-cap pure-plays), and the picks-and-shovels trade (post-quantum cryptography names like SEALSQ as NIST standards finalize). Treating these as one sector beta — the way most quantum-themed ETFs do — obscures more than it reveals.

Quantum Computing & Pre-IPO Markets is one of the four research verticals we cover in our education library. The Quantinuum filing and the D-Wave print together are exactly the kind of paired-event sequence that helps explain why backlog conversion, governance structure, and pre-IPO secondary pricing matter more than any single quarterly headline. Educated investors who can read both a bookings table and an S-1 control-rights section will see this sector more clearly than those reading the revenue line alone.